These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18852066)

  • 41. A perfect storm for innovation.
    Williams RN
    Clin Pharmacol Ther; 2010 Jul; 88(1):23; author reply 23-4. PubMed ID: 20445532
    [No Abstract]   [Full Text] [Related]  

  • 42. Molecular diagnostics and personalized medicine. IBC Life Sciences Conference on Pharmacogenomics, June 24-25, 2003, London, UK.
    Sanders R
    Pharmacogenomics; 2003 Sep; 4(5):541-5. PubMed ID: 14518454
    [No Abstract]   [Full Text] [Related]  

  • 43. Biopharma in Piedmont, Italy.
    Sakariassen KS
    Nat Rev Drug Discov; 2005 Jun; 4(6):519. PubMed ID: 15959953
    [No Abstract]   [Full Text] [Related]  

  • 44. [What is a real therapeutic advance].
    Assist Inferm Ric; 2002; 21(3):152-60. PubMed ID: 12593081
    [No Abstract]   [Full Text] [Related]  

  • 45. Market watch: Sales of biologics to show robust growth through to 2013.
    Goodman M
    Nat Rev Drug Discov; 2009 Nov; 8(11):837. PubMed ID: 19876035
    [No Abstract]   [Full Text] [Related]  

  • 46. Bhutan. Improbable partners aim to bring biotechnology to a Himalayan kingdom.
    Stone R
    Science; 2010 Feb; 327(5968):940-1. PubMed ID: 20167760
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pharmacology and pharmacotherapy in Japan].
    Van Zwieten PA
    Ned Tijdschr Geneeskd; 1990 Mar; 134(11):549-50. PubMed ID: 2320149
    [No Abstract]   [Full Text] [Related]  

  • 48. Uncorking the biomanufacturing bottleneck.
    Dove A
    Nat Biotechnol; 2002 Aug; 20(8):777-9. PubMed ID: 12148000
    [No Abstract]   [Full Text] [Related]  

  • 49. The future of pharmacology.
    Vallance P; Smart TG
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S304-7. PubMed ID: 16402118
    [No Abstract]   [Full Text] [Related]  

  • 50. Emergence and evolution of pharmacogenetics and pharmacogenomics in clinical pharmacy over the past 40 years.
    Streetman DS
    Ann Pharmacother; 2007 Dec; 41(12):2038-41. PubMed ID: 17956958
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacogenetics: improving drug and dose selection.
    Bhathena A; Spear BB
    Curr Opin Pharmacol; 2008 Oct; 8(5):639-46. PubMed ID: 18762278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The second annual Burrill personalized medicine conference.
    Razvi ES
    IDrugs; 2007 Jan; 10(1):26-9. PubMed ID: 17187310
    [No Abstract]   [Full Text] [Related]  

  • 53. Bills target biosimilar drugs.
    Wadman M
    Nature; 2009 Mar; 458(7237):394-5. PubMed ID: 19325595
    [No Abstract]   [Full Text] [Related]  

  • 54. Biotech at the beauty counter.
    Nasto B
    Nat Biotechnol; 2007 Jun; 25(6):617-9. PubMed ID: 17557090
    [No Abstract]   [Full Text] [Related]  

  • 55. bioLOGIC Europe 2008.
    Veryard C
    IDrugs; 2008 Dec; 11(12):884-8. PubMed ID: 19051149
    [No Abstract]   [Full Text] [Related]  

  • 56. Organic synthesis remains relevant in drug discovery.
    Mehrotra MM
    Nature; 2007 Oct; 449(7162):535. PubMed ID: 17914370
    [No Abstract]   [Full Text] [Related]  

  • 57. Getting information about biotechnology products.
    Piascik P
    Am Pharm; 1993 Apr; NS33(4):18-9. PubMed ID: 8475852
    [No Abstract]   [Full Text] [Related]  

  • 58. The challenges of product- and process-related impurities to an evolving biopharmaceutical industry.
    Bracewell DG; Smales CM
    Bioanalysis; 2013 Jan; 5(2):123-6. PubMed ID: 23330553
    [No Abstract]   [Full Text] [Related]  

  • 59. Too little, too late?
    Nature; 2006 Mar; 440(7084):603. PubMed ID: 16572143
    [No Abstract]   [Full Text] [Related]  

  • 60. Genentech faces the consequences of growth.
    Ransom J
    Nat Biotechnol; 2007 Apr; 25(4):371. PubMed ID: 17420731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.